Edition:
United States

DelMar Pharmaceuticals Inc (DMPI.OQ)

DMPI.OQ on NASDAQ Stock Exchange Capital Market

0.50USD
17 Aug 2018
Change (% chg)

-- (--)
Prev Close
$0.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
33,142
52-wk High
$2.29
52-wk Low
$0.36

Select another date:

Tue, May 22 2018

BRIEF-Delmar Appoints Saiid Zarrabian Full-Time President And CEO

* DELMAR APPOINTS SAIID ZARRABIAN TO FULL-TIME PRESIDENT AND CEO

BRIEF-DelMar Pharmaceuticals Reports Q3 Loss Per Share Of $0.13

* DELMAR PHARMACEUTICALS ANNOUNCES THIRD QUARTER FISCAL YEAR 2018 FINANCIAL RESULTS

BRIEF-DelMar Pharmaceuticals Presents Positive Updates on 2 Ongoing Clinical Trials with VAL-083 for Treatment of MGMT-unmethylated GBM

* DELMAR PHARMACEUTICALS PRESENTS POSITIVE UPDATES ON TWO ONGOING CLINICAL TRIALS WITH VAL-083 FOR TREATMENT OF MGMT-UNMETHYLATED GBM

BRIEF-Delmar Pharmaceuticals To Increase Number Of Authorized Shares Of Stock, Par Value Of $0.001, Per Share From 50 Mln Shares To 70 Mln Shares

* TO INCREASE NUMBER OF AUTHORIZED SHARES OF STOCK, PAR VALUE OF $0.001, PER SHARE FROM 50 MILLION SHARES TO 70 MILLION SHARES Source text: (https://bit.ly/2GWHkzx) Further company coverage:

Select another date: